WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2025 Issue has been successfully launched on 1 NOVEMBER 2025.

Abstract

INVESTIGATION OF NANOPARTICLE-BASED EXTRACTION AND PURIFICATION METHODS FOR TARGETED DRUG DELIVERY IN BREAST CANCER THERAPY

Nidhi Saxena, Kavita Shukla, Ankur Jain, Smriti Mathur, Anupam Verma, Gireesh Tripathi, Pratibha Devi and AbhishekShrivastava*

ABSTRACT

This study explores the development and optimization of an HPLC-based analytical and bioanalytical method for the targeted delivery of paclitaxel (PTX) and docetaxel (DTX) in breast cancer therapy using nanoparticle formulations. The study employed reverse-phase chromatography with a C18 column, suitable for the analysis of these chemotherapeutic agents due to their low molecular weight (<2000). The HPLC conditions were optimized for both the analytical and bioanalytical methods, which involved a linear gradient elution, precise mobile phase composition, and retention times specific to PTX and DTX. The method demonstrated robust analytical performance, with a PDA detector operating at a wavelength of 227 nm, providing optimal detection for the drugs. The solubility of PTX and DTX was tested under physiological conditions, revealing significant improvement upon nanoparticle formulation. Further, the characterization of the nanoparticles, including their particle size, zeta potential, and entrapment efficiency, was performed. These formulations displayed controlled release profiles, which were evaluated using various kinetic models. In vitro cytotoxicity tests confirmed the effectiveness of the nanoparticle formulations in killing breast cancer cells, with enhanced solubility and stability compared to the free drugs. The pharmacokinetic studies indicated improved drug bioavailability, as evidenced by prolonged circulation time and enhanced tumor accumulation. The results suggest that these nanoparticle-based drug delivery systems could provide significant improvements in the efficacy of PTX and DTX in breast cancer treatment.

Keywords: Nanoparticles, Paclitaxel, Docetaxel, HPLC, Targeted Drug Delivery, Breast Cancer, Solubility Enhancement, Pharmacokinetics.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More